Heat Biologics, Inc. (HTBX)
Heat Biologics has a market cap or net worth of $138.42 million. The enterprise value is $17.39 million.
The next earnings date is Monday, November 8, 2021 before market open.
|Estimated Earnings Date||Nov 8, 2021|
Heat Biologics has 25.14 million shares outstanding. The number of shares has increased by 100.11% in one year.
|Shares Change (YoY)||+100.11%|
|Shares Change (QoQ)||+3.87%|
|Owned by Insiders (%)||4.28%|
|Owned by Institutions (%)||12.20%|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
|EV / Earnings||n/a|
|EV / Sales||7.10|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 37.22, with a Debt / Equity ratio of 0.01.
|Debt / Equity||0.01|
|Debt / EBITDA||-0.06|
|Debt / FCF||-0.06|
|Return on Equity (ROE)||-23.20%|
|Return on Assets (ROA)||-21.90%|
|Return on Capital (ROIC)||-27.00%|
|Revenue Per Employee||$62,848|
|Profits Per Employee||-$753,297|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -34.81% in the last 52 weeks. The beta is 0.51, so Heat Biologics's price volatility has been lower than the market average.
|52-Week Price Change||-34.81%|
|50-Day Moving Average||5.99|
|200-Day Moving Average||6.49|
|Average Volume (30 Days)||206,983|
Short Selling Information
|Short % of Shares Out||8.49%|
|Short % of Float||8.78%|
|Short Ratio (days to cover)||6.39|
In the last 12 months, Heat Biologics had revenue of $2.45 million and -$29.38 million in losses. Earnings per share was -$1.27.
|Earnings Per Share (EPS)||-$1.27|
The company has $122.68 million in cash and $1.66 million in debt, giving a net cash position of $121.02 million or $4.81 per share.
|Cash & Cash Equivalents||122.68M|
|Net Cash Per Share||$4.81|
|Book Value Per Share||5.23|
In the last 12 months, operating cash flow was -$22.95 million and capital expenditures -$3.77 million, giving a free cash flow of -$26.72 million.
|Operating Cash Flow||-22.95M|
|Free Cash Flow||-26.72M|
|FCF Per Share||-$1.06|
Gross margin is 100.00%, with operating and profit margins of -1,224.78% and -1,198.61%.
Dividends & Yields
Heat Biologics does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The last stock split was on December 11, 2020. It was a reverse split with a ratio of 1:7.
|Last Split Date||Dec 11, 2020|